Causal relationship between T2DM microvascular complications and gut microbiota: a Mendelian randomization study

Area of Science:

• Investigates the complex interplay between the gut microbiome and metabolic health, specifically focusing on Type 2 Diabetes Mellitus (T2DM) and its microvascular complications.

Background:

• Growing evidence suggests an association between gut microbiota and microvascular complications in Type 2 Diabetes Mellitus (T2DM).
• The precise causal relationship between gut microbiome alterations and T2DM-related microvascular issues remains largely undetermined.

Purpose of the Study:

• To elucidate the causal links between specific gut microbial compositions and the development of T2DM microvascular complications.
• To leverage advanced genetic analysis techniques to establish causality in the gut microbiome-T2DM relationship.

Main Methods:

• Employed a Mendelian randomization (MR) approach, a robust method for inferring causality from genetic data.
• Utilized large-scale genome-wide association study (GWAS) data from the International MiBioGen Consortium (microbiome) and FinnGen Consortium (T2DM complications).
• Selected single nucleotide polymorphisms (SNPs) as instrumental variables and applied inverse variance weighting (IVW) for primary analysis, with checks for heterogeneity and horizontal pleiotropy.

Main Results:

• Identified causal relationships between specific gut microbial species and T2DM retinopathy, including 5 known and 2 unknown species.
• Revealed causal links involving 3 known microbial species for T2DM neuropathy.
• Established causal associations for 7 known microbial species concerning T2DM nephropathy.

Conclusions:

• The study provides strong evidence for a causal role of the gut microbiome in the pathogenesis of T2DM microvascular complications.
• Findings offer a novel perspective and potential therapeutic targets for preventing and managing T2DM-related microvascular damage.